Women with mental disorders less likely to have mammograms

October 26, 2006

INDIANAPOLIS -- Women with mental disorders are less likely to have screening mammograms than women without mental illness, although the nature of the mental illness does play a role, according to a large study published by Indiana University School of Medicine and Richard Roudebush VA Health Services Center for Excellence researchers in the October issue of Journal of General Internal Medicine. Prior to this study, little was known about whether the type or severity of mental illness influences receipt of preventive services such as mammograms.

"Although women with mental disorders are less likely to receive mammography than women who do not have mental disorders, we found that both the type and severity of mental illness does influence the receipt of mammograms. Women with psychotic disorders such as schizophrenia are significantly less likely to receive mammograms than women in the general population. However, women with mild depression do not differ markedly. But, as depression severity increases, so does the likelihood that women will not receive needed screening," said senior author Caroline Carney Doebbeling, M.D., M.Sc., associate professor of psychiatry and medicine at the I.U. School of Medicine. She is also a Regenstrief Institute, Inc. research scientist and director of the IU Cancer Center's CompleteLife program.

Severity contributed to lower receipt of mammography among women with mood and anxiety disorders, however women with psychotic, alcohol, and substance abuse disorders had decreased odds for receipt of mammography regardless of severity, the authors reported.

A comparison of insurance claims data for 59,673 women with a mental illness diagnosis and 131,683 women without this type of diagnosis indicated that the presence, type, and severity of the mental illness significantly influenced receipt of mammography throughout a five-year period. All the women in the study were between the ages of 40 and 64 and were privately insured.

Mammography has been shown to reduce death from breast cancer in women. The U.S. Preventive Services Task Force and the American Cancer Society recommend that all women undergo mammography a minimum of every 1 to 2 years beginning at age 40 years and annual screening beginning at age 50 years. According to the Centers for Disease Control, in 2002, 75.9 percent of women 40 years and older had a mammography screening in the past two years.

"Women with severe mental illness or psychotic and substance abuse disorders should be targeted to ensure delivery of mammography," said Dr. Carney Doebbeling, who is both a psychiatrist and an internist.
-end-
Laura E. Jones, M.Sc., is co-author of the study which was supported by the National Institute of Mental Health.

Indiana University

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.